The sickling process in relation to clinical manifestations.

Area of Science:

• Molecular biology
• Hematology
• Pharmacology

Background:

• Sickle cell disease (SCD) management relies on understanding molecular mechanisms of red blood cell sickling.
• Current therapies focus on managing SCD crisis triggers: fever, hypoxia, acidosis, and dehydration.
• Many previously investigated anti-sickling drugs have not proven effective over time.

Purpose of the Study:

• To review the current understanding of sickle cell disease molecular mechanisms.
• To discuss the rationale behind current therapeutic approaches for sickle cell disease.
• To explore the potential for developing novel, targeted anti-sickling therapies.

Main Methods:

• Literature review of molecular mechanisms in sickle cell disease.
• Analysis of current therapeutic strategies for managing sickle cell crises.
• Evaluation of past and potential future anti-sickling drug development.

Main Results:

• Detailed knowledge of sickling molecular processes informs effective management strategies.
• The partial success of cyanate is linked to its basis in molecular understanding.
• Identifying specific intermolecular binding sites in sickling is key for future drug development.

Conclusions:

• Molecular insights into sickle cell disease are crucial for effective treatment.
• Targeted drug development for sickle cell disease is becoming more feasible.
• Continued research into sickling mechanisms promises more specific and effective therapies.